> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Fresenius Recalls Two Fluorouracil Lots
- URL: https://www.fdaweb.com/fresenius-recalls-two-fluorouracil-lots/
- Published: 2019-07-08T12:00:00.000Z
- Updated: 2026-09-15T01:36:09.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5144461

Fresenius Kabi USA has recalled two lots of fluorouracil injection, USP 5g/100ml (50mg/ml), 100ml fill in 100ml vials, due to the potential for them to contain glass particulates. “Products containing glass particulate should not be administered intravenously due to the potential for life-threatening consequences,” a [recall notice](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/fresenius-kabi-issues-voluntary-nationwide-recall-two-lots-fluorouracil-injection-due-potential?ref=fdaweb.com) says. To date, the company says it has not received any complaints related to the recall. Fluorouracil is a chemotherapy drug that is administered intravenously and indicated for treating several cancers.